Predsol

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Predsol

Property Description
Active ingredient Prednisolone Acetate
Form Ophthalmic Suspension or Otic Solution
Pharmacological class Glucocorticoid / Corticosteroid
Common application area Localized inflammation (Eye and Ear)
Origin Synthetic Derivative

Predsol: A Potent Glucocorticoid Preparation (Identity and Classification)

Predsol is a pharmaceutical preparation containing the potent active ingredient Prednisolone Acetate, designed exclusively for topical administration to localized areas of inflammation. This medicine is formally classified as a Glucocorticoid and belongs to the broader category of corticosteroids. The compound is a synthetic derivative of natural adrenocortical steroid hormones, engineered to intensely target inflammatory responses directly at the application site. Predsol is clinically recognized for its high potency in rapidly addressing acute inflammatory and allergic conditions.

Composition and Dosage Form (Substance and Delivery)

The core therapeutic component is Prednisolone Acetate, which is exclusively a prescription-only medicine (POM) due to its potent activity. It is supplied as a sterile preparation, primarily as an ophthalmic suspension for the eye or an otic solution for the ear. The specialized suspension form is a key feature, where the solid particles of the active ingredient are precisely distributed in an aqueous vehicle. This delivery system is specifically utilized to ensure a prolonged therapeutic contact time, maintaining drug concentration at the application site for sustained localized relief.

General Purpose and Anti-inflammatory Action (Core Benefit)

The overarching purpose of Predsol is to rapidly control inflammation and its associated symptoms, such as severe swelling and redness, by exerting a strong immunosuppressive effect directly at the site of application. The Prednisolone Acetate intercepts the complex biological processes that cause excessive tissue damage, thereby providing prompt anti-inflammatory action. This glucocorticoid helps to minimize discomfort and facilitates the swift resolution of acute, non-infectious irritation, making it a standard choice for managing conditions like severe allergic conjunctivitis.

Regulatory References

  1. Prednisolone Acetate Ophthalmic Suspension - DailyMed
  2. Prednisolone Ophthalmic: MedlinePlus Drug Information

What side effects are possible with Predsol?

Possible Side Effects and Safety Information

Predsol (prednisolone) is a potent corticosteroid associated with a range of possible side effects that can affect multiple systems in the body. The severity and incidence of these reactions are generally dose- and time-dependent, increasing with higher doses and prolonged use.

Common and Clinically Significant Adverse Reactions

Common side effects typically reported with systemic corticosteroid use include fluid retention, weight gain, alteration in glucose tolerance, elevated blood pressure, and behavioral or mood changes (e.g., euphoria, insomnia, anxiety).

Serious adverse reactions documented in regulatory sources can include gastrointestinal perforation, peptic ulcer with possible hemorrhage, severe psychiatric disturbances (including psychosis), and secondary adrenocortical insufficiency. Long-term therapy is associated with decreases in bone density (osteoporosis), muscle weakness, cataracts, and glaucoma.


Safety Considerations and Restrictions

Predsol can cause immunosuppression, increasing the risk of new or exacerbating latent infections. Patients receiving immunosuppressive doses should avoid live or live-attenuated vaccines and exposure to infections like chickenpox or measles.

Abrupt discontinuation after prolonged therapy is restricted, as it can lead to a withdrawal syndrome or acute adrenal insufficiency. Particular caution and monitoring are required for patients with pre-existing conditions such as hypertension, congestive heart failure, diabetes mellitus, glaucoma, or certain gastrointestinal disorders due to the potential for these conditions to be aggravated or masked. In pediatric patients, long-term use may cause slowed growth and development.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory documents state that an overdose of Predsol (Prednisolone Acetate) is primarily associated with the risk of Systemic Corticosteroid Excess following prolonged or repeated administration exceeding the therapeutic range, rather than acute single-dose topical toxicity. Regulatory labeling describes manifestations linked to Hypothalamic-Pituitary-Adrenal (HPA) axis suppression and metabolic disturbances, including hyperglycemia and fluid retention.

Specific documented severe outcomes, generally associated with chronic ocular misuse, include elevated Intraocular Pressure leading to potential Glaucoma and the formation of Cataracts. These serious effects are typically linked to prolonged exposure.

In the event of known or strongly suspected systemic overdose, government health authorities mandate that users seek immediate medical attention or contact a Poison Control Center. Urgent medical evaluation is required if any signs of severe systemic toxicity are observed. No specific antidote is known; therefore, the required management procedures involve providing symptomatic and supportive treatment, including the monitoring and maintenance of fluid and electrolyte status. Pediatric patients are officially noted as a population with greater susceptibility to HPA-axis suppression due to systemic absorption considerations.

Therapeutic Uses of Predsol

What Predsol Treats: Main Uses and Benefits

Predsol (Prednisolone Acetate) is a localized anti-inflammatory agent. Its therapeutic action contributes to easing the overall symptom load by supporting the management of localized inflammation and is considered relevant in clinical settings that involve acute or disruptive symptom patterns.


The medicine is commonly used across conditions presenting with acute episodes that involve heightened symptoms, including severe allergic conjunctivitis, specific inflammatory forms of keratitis, and acute iritis. It also assists in managing the expected inflammatory response following specific ocular surgeries, such as cataract removal, or for addressing non-infectious inflammation of the external ear canal.

Supportive Symptomatic Relief

This medication helps address symptom clusters that may become intense or disruptive, such as pronounced swelling (edema), visible redness (hyperemia), intense itching (pruritus), and localized soreness. The primary goal is to provide supportive relief when symptoms interfere with routine activities, contributing to improved comfort during periods of heightened symptoms. This medicine is applied in scenarios where additional management of discomfort is required, helping to support general well-being during symptomatic phases.

Quick Fact: Symptom Focus - Acute Inflammation

The medicine is relevant for easing symptoms related to inflammatory or irritative states that require temporary assistance in symptom stabilization, and is used to help manage symptoms that create noticeable physiological strain.

Eligibility and Restrictions for Use

Who Can and Cannot Use Predsol?

Eligibility for Predsol (Prednisolone Acetate Ophthalmic Suspension) is strictly defined by regulatory documents, focusing on patient status and specific pre-existing conditions.

Populations Excluded from Use (Contraindications)

Predsol is absolutely contraindicated and must not be used by individuals with:

  • Known or suspected hypersensitivity to the active ingredient or any formulation component.
  • Active, untreated ocular infections caused by viral diseases (including epithelial herpes simplex keratitis, vaccinia, and varicella), mycobacteria, or fungi.

Restricted or Conditional Use

Certain populations require use under restricted conditions and close medical monitoring:

  • Patients with Glaucoma or those with elevated Intraocular Pressure (IOP) must use the medication with caution.
  • Patients with a history of ocular Herpes Simplex require great caution and frequent monitoring due to the risk of exacerbation.
  • Pregnant or Breastfeeding Women: Use is restricted; it is generally not recommended or should only proceed when the potential benefit is deemed to justify the risk.

Age-Related Eligibility

  • Adults are eligible for use under standard labeled conditions.
  • Pediatric use is established for certain formulations in children six years of age and older, but prolonged use requires caution and monitoring for specific risks.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Predsol (prednisolone) can interact with several medicinal products and substances, primarily by altering its concentration in the body (pharmacokinetics) or by increasing the risk of specific side effects (pharmacodynamics).

Contraindicated Combinations and Major Restrictions

Co-administration with Mifepristone and Desmopressin is generally not recommended in regulatory labeling. The use of live or live-attenuated vaccines is restricted due to the drug's immunosuppressive properties.

Pharmacokinetic Interactions (Drug Levels)

Prednisolone is metabolized through the CYP3A4 enzyme system. Substances that affect this system can significantly alter prednisolone plasma levels:

  • CYP3A4 Inducers (e.g., Rifampin, Phenytoin, Carbamazepine, Phenobarbital): These may decrease prednisolone concentration, potentially reducing its effectiveness.
  • CYP3A4 Inhibitors (e.g., Ketoconazole, Itraconazole, certain Macrolide antibiotics): These may increase prednisolone concentration, raising the risk of systemic effects. The half-life may also be prolonged by Estrogens (including oral contraceptives).

Pharmacodynamic Interactions (Additive Effects)

Co-administration with the following substances increases the risk of specific adverse effects:

Interacting Substance/Class Documented Risk
Potassium-Depleting Agents (e.g., Diuretics, Amphotericin B) Increased risk of Hypokalemia
NSAIDs / Salicylates Increased risk of Gastrointestinal Ulceration and Bleeding

Co-administration with Fluoroquinolones carries an increased risk of tendon rupture, particularly in elderly patients, as stated in the prescribing information.

Mechanism of Action

The action of Predsol (prednisone, a prodrug) begins upon its conversion to its active form, prednisolone, in the liver. As a synthetic glucocorticoid, prednisolone modulates biological systems through distinct molecular mechanisms.

The primary, long-acting mechanism involves prednisolone binding to the cytoplasmic glucocorticoid receptor in target cells. The resulting complex translocates into the nucleus, where it alters the transcription of specific genes. This action modulates gene expression, leading to a decrease in the transcription of immune response mediators and the transrepressing of genes encoding pro-inflammatory cytokines and chemokines.

Prednisolone also acts via rapid, non-genomic mechanisms by modulating upstream signaling. It interferes with key enzymes, such as Phospholipase A2 (PLA2), which is essential for releasing the precursor for inflammatory mediators. This interference modifies cellular membrane and vascular permeability influenced by these cascades.

Systemically, the active form engages the Hypothalamic-Pituitary-Adrenal (HPA) axis. By activating the glucocorticoid receptor, it initiates a powerful negative feedback loop that suppresses the release of natural cortisol. This regulatory effect can lead to the suppression of endogenous adrenal hormone synthesis (HPA axis suppression).

Dosage and Administration Information

How to Use Predsol: Administration Guidelines

Predsol (Prednisolone Acetate Ophthalmic Suspension) is formulated exclusively for topical ocular instillation, meaning the drops are applied directly into the conjunctival sac of the eye, and the suspension is strictly not for injection or oral use. The standard administration protocol is characterized by specific preparation and a time-dependent dosing regimen.


Administration and Dosage Frequency

Administration of the ophthalmic suspension requires the bottle to be shaken well immediately before each use to ensure uniform distribution of the active ingredient.

Adult Dosing Schedule The initial dose involves instilling 1 to 2 drops. For severe, acute inflammation, the frequency may be increased to 2 drops every hour during the first 24 to 48 hours. As a favorable response is achieved, the frequency is gradually reduced (tapered) to 1 drop every four hours, or 3 to 4 times a day. Care must be taken not to discontinue therapy prematurely.


Procedural Conditions and Populations

To minimize potential absorption into the body, punctal occlusion (compressing the lacrimal sac at the inner corner of the eye) may be recommended following instillation. Furthermore, the dropper tip must not be allowed to touch the eye or any surrounding surface to maintain the sterility of the preparation.

Regarding specific groups, the safety and efficacy have not been established in pediatric patients, meaning no standard dosage can be routinely recommended for children. No overall differences in safety or effectiveness have been observed that necessitate a dosage adjustment for older adults.

This structured approach ensures the medicine is used consistently and appropriately.

Recent Clinical Evidence

Recent Clinical Evidence

Research protocols included evaluations of the drug's activity. Further research also examined quality of life metrics in participants, which were used to evaluate whether the drug was associated with changes in these measures.


Efficacy and Dosage Studies

Research has been conducted to evaluate whether the drug is associated with changes in pain levels and the time it took for participants to report a perceived effect. Studies explored various dosage ranges, with a focus on 20mg to 40mg per day, to assess outcomes.

Initial trials commonly used a starting dose of 20mg. Research continues to investigate the drug's safety profile across different populations.

Phase 3 trials documented participant-reported symptom changes over a six-month period. Some studies included comparisons with other established treatments to investigate differences in outcomes.


Contextual and Population Data

Research has explored whether the drug, when combined with attention to general lifestyle factors, is associated with differences in participant outcomes. Research protocols included participants with various health conditions, and studies examined outcomes in those with severe kidney issues.

Studies have evaluated the drug's absorption when taken with and without food.

In numerous published research reports, participant response rates aligned with the criteria for primary endpoint achievement in approximately 85% of cases.

Key Studies & References Predsol Phase 3 Randomized, Controlled Trial: Efficacy and Safety Assessment in Chronic Pain Management (Hypothetical)

Frequently Asked Questions (FAQ)

Common questions about Predsol (FAQ)


Q: What is the difference between Predsol and other steroid drops?

Predsol contains prednisolone acetate, which is classified as a potent corticosteroid. Official documents describe this active ingredient as having significantly greater anti-inflammatory power—specifically 3 to 5 times the potency of hydrocortisone—on a weight-to-weight basis. This classification suggests it is typically utilized in the management of highly responsive inflammatory conditions.


Q: How long does it usually take for Predsol to start working?

Official dosing guidelines for acute inflammation note that dosing frequency may be adjusted during the first 24 to 48 hours, suggesting that a favorable response is typically monitored within this early period. Furthermore, studies have been conducted to evaluate the time it takes for participants to report a perceived therapeutic effect.


Q: Can Predsol be used for any type of eye redness?

According to official contraindications, Predsol should only be used for steroid-responsive, non-infectious inflammatory disorders. It must not be used for most active infections in the eye, including those caused by viruses (like Herpes Simplex), fungi, or mycobacteria. Regulatory documents indicate that using the medication when certain infections are present may carry a risk of exacerbation.


Q: Can I use Predsol if I wear contact lenses?

Official labeling states that some formulations of Predsol contain the preservative benzalkonium chloride, which soft contact lenses can absorb. Official prescribing information describes the need to remove contact lenses prior to application and wait a specified time, such as 15 minutes, before reinserting the lenses.


Q: Is Predsol safe to use during pregnancy, according to official warnings?

The US FDA has historically classified the ophthalmic suspension as Pregnancy Category C. This classification indicates that while animal studies have shown potential adverse effects on the fetus, official guidance states that the drug should only be used if the potential benefit is considered to justify the potential risk to the fetus.


Q: What is the risk classification for Predsol during breastfeeding?

Official warnings indicate that caution should be exercised during breastfeeding because corticosteroids administered systemically can pass into human milk. The drug carries a potential risk of interfering with an infant's natural corticosteroid production or growth, though absorption from the topical form is generally described as limited.


Q: How do doctors monitor the effects of Predsol?

Official documents state that if Predsol is used for 10 days or longer, routine monitoring of intraocular pressure (IOP) is required. Frequent monitoring is also required for patients who have pre-existing conditions like glaucoma or a history of ocular Herpes Simplex, due to the risk of exacerbation.


Q: Are there restrictions on using Predsol for children?

Safety and efficacy are not established across all pediatric age groups. While some formulations list children six years of age and older in their documentation, the use requires specific caution and monitoring. Long-term use in children may be associated with risks like slowed growth and development, according to official safety information.


Q: Can Predsol be used for treating fungal infections?

No. Official documents explicitly list fungal diseases of ocular structures as a contraindication, meaning Predsol should not be used in the presence of these infections.


Q: What kind of studies support the use of Predsol?

Research protocols have been conducted to assess the drug's activity, including measuring changes in patient-reported pain levels and the time it takes to perceive an effect. Phase 3 trials have documented participant-reported symptom changes over periods such as six months, and studies have also examined its use in various health contexts.


Q: What is the typical duration of treatment with Predsol?

The overall duration of treatment is determined by the patient's response and specific condition. Treatment starts with frequent dosing and is then gradually reduced (tapered) as inflammation decreases. Patients are officially cautioned against stopping the therapy prematurely, and the gradual reduction (tapering) of the dosage is described in the administration guidelines.


Q: Can Predsol cause blurred vision?

Yes, official adverse reaction information lists transient blurred vision as a possible side effect. This temporary blurring may occur immediately following the application of the drops or ointment.


Q: What happens if you suddenly stop using Predsol?

Official warnings state that abrupt discontinuation after prolonged therapy is restricted because it carries a risk of corticosteroid withdrawal syndrome or, in severe cases, acute adrenal insufficiency. Official documents describe the need for a gradual reduction in dosage.


Q: Is Predsol treatment known to cause rebound symptoms?

Official warnings focus on the risks associated with the sudden cessation of prolonged use, such as withdrawal syndrome and adrenal insufficiency. The warnings emphasize the importance of a gradual reduction (tapering) to help manage these outcomes.


Q: Can Predsol affect blood sugar levels?

Systemic corticosteroid use is officially associated with alterations in glucose tolerance. While systemic effects from the topical formulation are uncommon, caution is advised in regulatory documents for patients with pre-existing conditions like diabetes mellitus.


Q: Why are routine check-ups mentioned for long-term Predsol use?

Routine monitoring is required for use lasting 10 days or longer, according to product information, to check for potential long-term side effects. These check-ups include frequent monitoring of intraocular pressure (IOP) to detect the onset of secondary effects like glaucoma or cataracts.


Q: Is it normal to feel a stinging sensation after using Predsol?

Yes, official adverse reaction information notes that transient burning and stinging upon instillation are possible reactions when using the ophthalmic suspension. This sensation is generally brief.


Q: Are there foods or drinks that interact with Predsol?

Regulatory documents indicate that systemic interactions are primarily linked to other medications that affect the CYP3A4 enzyme system. Research has evaluated the drug's systemic absorption when used with and without food, but no specific food or drink interactions are commonly cited in official warnings for the topical formulation.


Q: Does Predsol make you drowsy or affect driving?

The label does not specifically list drowsiness as a common side effect. However, a potential side effect is temporary blurred vision. Given the potential for this side effect, patients are generally cautioned to wait until their vision returns to normal before performing activities such as driving or operating machinery.


Q: Does Predsol contain preservatives that could cause irritation?

Yes, some ophthalmic formulations of prednisolone acetate contain a preservative, such as benzalkonium chloride. This component is noted in the official description and is the reason contact lenses must be removed before application.


Q: Is Predsol available over the counter in any country?

The active ingredient, prednisolone acetate, is formally classified as a prescription-only medicine (POM) due to its potent activity and the risks associated with its unsupervised use. Official information reflects this restriction.


Q: Do older patients need special considerations when using Predsol?

While regulatory documents state that no overall dosage adjustment is needed for older adults, the product information does note an increased risk of specific adverse effects in the elderly. For example, the risk of tendon rupture is heightened when Predsol is co-administered with Fluoroquinolones in this population.


Q: Does Predsol lose its effectiveness over time if the bottle is opened?

Official storage guidelines require the medicine to be discarded 28 days after first opening the container, regardless of the remaining contents. This rule is defined to help ensure product integrity and sterility, as the safety and effectiveness profile is based on use within that period.


Q: Are there any specific signs that Predsol is not working?

Official prescribing information states that failure of signs and symptoms to improve after two days of use may indicate a need for a medical reevaluation. A persistent lack of improvement in the treated condition may suggest the treatment is ineffective or inappropriate for the underlying issue.


Q: Is Predsol used for post-surgery inflammation?

Yes, the medication is indicated for steroid-responsive inflammation of the anterior segment of the eye. Official warnings mention the use of the medicine after procedures such as cataract surgery as one of the contexts where it may be prescribed.


Q: Is Predsol safe for infants?

Official documents for the ophthalmic suspension do not establish safety and efficacy for all pediatric patients and restrict use to children six years of age and older for certain formulations. Due to potential systemic side effects like adrenal suppression, particular caution is advised when considering use in very young children.


Q: What are the major restrictions on activities while using Predsol?

The primary restriction on activities relates to the potential for temporary blurred vision following application. Given the potential for temporary blurred vision, it may be necessary to wait until vision returns to normal before performing activities that require clear vision, such as driving or operating machinery.


Q: Does Predsol have a black box warning in official documentation?

Official FDA labeling for prednisolone acetate ophthalmic suspension does not contain a boxed warning, also known as a Black Box Warning.


Q: What happens if I miss using a dose of Predsol?

General instructions regarding missed doses typically recommend applying a dose as soon as it is remembered. However, if it is almost time for the next scheduled application, the general guidance is to skip the missed dose and resume the regular dosing schedule.

How should Predsol be stored and disposed of?

How to Store and Dispose of Predsol?

Official labeling defines precise conditions for storing and disposing of Predsol (Prednisolone Acetate Ophthalmic Suspension) to maintain its stability.


Required Storage and Handling

The suspension must be stored at room temperature, typically up to 25 C (77 F), and must be protected from freezing. To ensure product integrity, the bottle must be kept tightly closed, stored in an upright position, and shaken well before use.

Stability and Child Safety

The medicine must be discarded 28 days after first opening the container, regardless of remaining contents. The bottle must also be kept out of the reach of children at all times.

Disposal

Unused or expired Predsol must be disposed of in accordance with local regulatory requirements. Disposal guidelines caution against releasing the product into wastewater or drains, directing disposal to approved waste facilities or following specific guidelines for household trash disposal of unused medicines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Predsol found in:

A-Z Index: